Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 10,158 shares at $114.03 ($1.2M) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Seasonal sale ($1.2M) by Chief Commercial Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.03 | 809 | $92K | 7.8% |
| 2 | $114.03 | 809 | $92K | 7.8% |
| 3 | $116.76 | 1,395 | $163K | 13.8% |
| 4 | $116.76 | 1,395 | $163K | 13.8% |
| 5 | $116.84 | 2,030 | $237K | 20.1% |
| 6 | $116.84 | 2,030 |
| $237K |
| 20.1% |
| 7 | $116.89 | 845 | $99K | 8.4% |
| 8 | $116.89 | 845 | $99K | 8.4% |
| Total | $116.38 avg | 10,158 | $1.2M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |